Inhibitor oligonucleotides and their use for specific...

Details Inhibitor oligonucleotides and their use for specific... Inhibitor oligonucleotides and their use for specific...

2008-05-13

2008-05-13

Angell, Jon E. (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024500, C435S006120, C435S375000

Reexamination Certificate

active

07371735

ABSTRACT:
A method of treating a disease resulting from the expression of a harmful gene is described. The method includes the step of administering a therapeutically effective amount of a pharmaceutical composition having at least one double stranded oligonucleotide including two complementary oligonucleotide sequences forming a hybrid. Each oligonucleotide sequence comprises at one of their 3′ or 5′ ends one to five unpaired nucleotides forming single-strand ends extending beyond the hybrid. One of the oligonucleotide sequences is substantially complementary to a target sequence belonging to a DNA or messenger RNA molecule of a gene coding a mutated or nonmutated androgen receptor.

REFERENCES:
patent: WO 00/20432 (2000-04-01), None
patent: WO 00/66724 (2000-11-01), None
patent: WO 01/36646 (2001-05-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 02/055692 (2002-07-01), None
patent: WO 03/070969 (2003-08-01), None
Kennerdell et al., Heritable gene silencing in Drosophila using double-stranded RNA, Jul. 2000, Nature Biotechnology, vol. 17, pp. 896-898.
Opalinska et al., Nucleic-acid therapeutics: Basic principles and recent applications, Jul. 2002, Nature Reviews Drug Discovery, vol. 1, pp. 503-514.
Tuschl et al., Samll interfering RNAs: A revolutionary tool for the analysis of gene function and gene therapy, Jun. 2002, Molecular Interventions, vol. 2, pp. 158-167.
Definition of “prevent”, Merriam-Webster Online Dictionary, http://m-w.com/dictionary/prevent, p. 1 of 1 is enclosed, Accessed and printed on Nov. 24, 2006.
Sayda M. Elbashir et al.,RNA interference is mediated by 21- and 22-nucleotide RNAs, Genes & Development, vol. 15, No. 2, Jan. 15, 2001, pp. 188-200 (XP002206453).
Sayda M. Elbashir et al.,Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, NATURE, vol. 411, No. 6836, May 24,2001, pp. 494-498 (XP002206451).
Sayda M. Elbashir et al.,Knockdown of mammalian gene expression using small interfering RNAs, Biology of the Cell, vol. 93, No. 3-4, Oct. 2001, pp. 259 (XP002206454).
Sayda M. Elbashir et al.,Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate, The EMBO Journal, vol. 20, No. 23, Dec. 3, 2001, pp. 6877-6888 (XP0002225998).
Takashi Futami et al.,Induction of apoptosis in HeLa cells with siRNA expression vector targeted against be1-2, Nucleic Acids Research, Supplement, No. 2, pp. 251-252 (XP002264267), Database Medline Accession No. NLM12903200.

Affiliated with

Also associated with

Rating

Inhibitor oligonucleotides and their use for specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitor oligonucleotides and their use for specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitor oligonucleotides and their use for specific... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2767885